Biological warfare is the deliberate spreading of disease
amongst humans, animals, and plants. Biological weapons
introduce a bacteria or virus into an environment for
hostile purposes, that is not prepared to defend itself
from the intruder. As a result, this agent can become
very effective at killing plants, livestock, pets, and
humans. There are a huge variety of genetically or traditionally
modified bacterias and viruses to withstand antibiotics,
that could be used as biological weapons, but some of
the most common types today are bacteria, rickettsiae,
viruses, toxins, and fungi.
Bacteria
Bacteria are single-cell organisms. Bacteria vary greatly
in their level of lethality and infectivity. Although
many pathogenic bacteria are susceptible to antibiotic
drugs, strains can be selected that are resistant to antibiotic
and occur naturally. Bacteria can be readily grown in
artificial media using facilities similar to those found
in the brewery industry.
Examples of Bacteria: Bacillus Anthracis (causes
anthrax), Yersinia pestis (causes plague), Brucella suis
(causes brucellosis) Pasturella tularensis (causes talaremia
also known as rabbit fever or deer fly fever) Vibrio cholera(causes
cholera) , and many other less dramatic but still pathogenic
species like Salmonella typhi and Staphylococcus aureus.
Effects of anthrax: About 1-6 days after inhaling Bacillus
anthracis spores there would be a gradual onset of vague
symptoms of illness such as fatigue, fever, mild discomfort
in the chest and a possibly a dry cough. The symptoms
would improve for a few hours or 2-3 days. Then, there
would be sudden onset of difficulty in breathing, profuse
sweating, cyanosis (blue colored skin), shock and death
in 24-36 hours.
These symptoms are essentially those of Woolsorter's
disease, which is caused by inhalation of Bacillus anthracis
spores rather than contact with the bacterium through
the skin. Contact through the skin is the most common
"naturally" occurring form of Anthrax and is characterized
by swelling and boils on the skin. Skin symptoms would
not necessarily be expected with Anthrax resulting from
inhaled spores in BW.
Rickettsiae
Rickettsiae are similar to bacteria in structure and
form, but must be grown in living tissue. Examples of
Rickettsiae: Coxiella burnetti (causes Q fever) and Rickettsia
prowasecki(causes epidemic typhus).
Effects of Rickettsiae: Gradual onset of fever
with severe headache, chills, generalized pains and dry
cough (sometimes developing to bronchopneumonia) of about
2 weeks. A macular rash appears by about 5 days, first
appearing on the trunk and lasting about six days. CNS
manifestations are possible. Damage is caused to vascular
endothelia by invasion of rickettsiae, possibly leading
to thrombosis and hemorrhage. http://www.mitretek.com/mission/envene/biological/agents/rickettsia.html
Viruses
Viruses are 100 times smaller than bacteria. They mostly
consist of DNA and need other living organisms to replicate.
Viruses can mutate to adapt to their environments, either
naturally or through genetic engineering to increase their
pathogenicity/virulence. Examples of viruses include:
Variola virus (causes smallpox), and Venezuelan Equine
Encephalitis (causes VEE), Yellow fever virus (causes
yellow fever), Ebola virus (causes Ebola hemmorrhagic
fever), Hanta Virus (causes a haemorraghic fever as well)
Effects of Variola virus: The usual entry of variola
virus is through the respiratory tract with infection
of the oropharyngeal (mouth) or respiratory (trachea and
lung) mucosa. Secretions from the mouth and nose, rather
than scab material, are the most important source of human-to-human
transmission. The initial infection in the oropharynx
or respiratory tract produces neither symptoms nor local
lesions, and patients are not infectious until an oropharyngeal
enanthem appears at the end of the primary incubation
periodScab material forms as the rash dries and usually
consists of large fragments of cellular debris, with virions
bound within a dense, fibrous mesh containing a large
amount of the antiviral substance interferon.
Toxins
Toxins are the non-living products of micro-organisms.
Although they are often subsumed under bioweapons agents,
they represent a special category, sharing many characteristics
with chemical warfare agents. Toxins can also be produced
by chemical synthesis. Toxins, like chemical warfare agents,
can only affect those exposed to the toxin and cannot
produce transmissible diseases. Because they are non-living
organisms, producing a large quantity of toxins requires
more time than would be needed to make a similar quantity
of other biological agents.
Examples of Toxins include: Saxitoxin (produced
by blue green algae), Botulinum toxin (causes botulism),
Ricin (derived from castor beans), Staphylococcal enterotoxin
B (causes fever, vomiting, nausea)
Effects of botulinium toxin: Botulinum toxin,
produced by the bacteria Clostridium botulinum, is the
most poisonous substance known. The bacteria grows on,
e.g., poorly preserved food and causes a severe form of
food-poisoning (botulism). The incubation period is between
one and three days after which the victim becomes ill
with stomach pains, diarrhoea, disturbances to vision,
giddiness and muscular weakness. The whole body including
the respiratory musculature becomes paralyzed which leads
to death by suffocation within a few days. http://www.opcw.nl/chemhaz/toxins.htm
Fungi
Fungi are almost entirely multicellular (with yeast,
Saccharomyces cerviseae, being a prominent unicellular
fungus), heterotrophic (deriving their energy from another
organism, whether alive or dead), and usually having some
cells with two nuclei (multinucleate, as opposed to the
more common one, or uninucleate) per cell. Evolution of
multicellular eukaryotes increased the size and complexity
of organisms, allowing them to exploit the terrestrial
habitat. First classified as plants, fungi are now considered
different enough from plants to be placed in a separate
kingdom. Fungi also are important crop parasites, causing
loss of food plants, spoilage of food and some infectious
diseases.
Examples of Fungi infectious diseases include:
Aspergillosis, Blastomycosis, Candida, Coccidioidomycosis,
Cryptococcosis, Histoplasmosis, Mucormycosis, Paracoccidioidomycosis,
Sporotrichosis Effects of fungi: Isolated skin lesion(s),
focal lesions of bone, central nervous system, visceral
organs, and if you are a male, lesion in the genito-urinary
system
Other anti-human agents, better known as anti-plant
and anti-animal agents: Anti-Animal Biological Agents
include: Aspergillus (poultry), Foot and Mouth Disease
(cattle, pigs, sheep, goats), Heartwater (cattle, sheep,
goats, deer), Newcastle Disease (poultry), Rinderpest
(cattle)
Anti-Plant Biological Agents include: Rice Blast
(fungus causing lesion on leaves), Stem Rust (fungal disease
affecting cereal crops), Sugarbeet Curly Top Virus (dwarfed
leaves and swollen veins), Tobacco Mosaic Virus (virus
affectnig wide range of plants, stunted growth)
Deadly and Cheap
When compared to the cost of a nuclear weapons program,
biological weapons are extremely cheap. It is estimated
that 1 gram of toxin could kill 10 million people. A purified
form of botulinum toxin is approximately 3 million times
more potent than Sarin, a chemical nerve agent. As a comparison,
a SCUD missile filled with botulinum toxin could affect
an area of 3700 sq.km, an area 16 times greater than could
be affected with Sarin.
It is important to note that while it is relatively cheap
to produce the biological weapons agents in large quantities,
sophisticated weapons are slightly more difficult to develop
and produce. For example, when a missile is flying it
gets very hot, biological agents are killed. Therefore,
the missile has to be fitted with a cooling system. In
addition, storing biological weapons agents requires much
effort, due to the quick decay of many of these sorts
of agents. However, as far as weapons of mass destruction
are concerned, biological weapons are relatively cheap
to develop and produce. In one analysis, the comparative
cost of civilian (unprotected) casualties is "$2,000 per
square kilometer with conventional weapons, $800 with
nuclear weapons, $600 with nerve-gas weapons, and $1 with
biological weapons." Not surprisingly, biological weapons
have long since become known as the poor man's atom bomb.
Any nation with a reasonably advanced pharmaceutical
and medical industry has the capability of mass producing
biological weapons. This fact also leads to problems with
determining what countries have programs. Anything from
a piece of fruit to a ballistic missile could be used
to deliver a biological weapon to a target. Along with
this is the fact that with certain organisms, only a few
particles would be needed to start an infection that could
potentially cause an epidemic. Conventional weapons explode
once and are finished. With a few particles of Hanta virus
many thousands of people could become carriers that infect
thousands more people.
A seed culture of anthrax bacteria could be grown to
mass quantities in around 96 hours. The level of technology
needed to do this kind of work is also much lower when
compared to Nuclear weapons. Most of the techniques used
can be found in textbooks and journals available worldwide.
The information is not considered "hot" like certain kinds
of nuclear information. The techniques are taught in undergraduate
courses in Colleges and Universities worldwide.
2. When have biological
weapons been used - a short history
The first recorded use of biological agents is the Romans
using dead animals to foul the enemies water supply. This
had the dual effects of decreasing enemy numbers and lowering
morale.
1346-1347 - Mongols catapult corpses contaminated
with plague over the walls into Kaffa (in Crimea), forcing
besieged Genoans to flee. Some historians believe that
this event was the cause of the epidemic of plague that
swept across medieval Europe killing 25 million.
1710 - Russian troops allegedly use plague-infected
corpses against Swedes 1767 - During the French and Indian
Wars, the British give blankets used to wrap British smallpox
victims to hostile Indian tribes
1916-1918 - German agents use anthrax and the
equine disease glanders to infect livestock and feed for
export to Allied forces. Incidents include the infection
of Romanian sheep with anthrax and glanders for export
to Russia, Argentinian mules with anthrax for export to
Allied troops, and American horses and feed with glanders
for export to France 1937 - Japan begins its offensive
biological weapons program. Unit 731, the BW research
and development unit, is located in Harbin, Manchuria.
Over the course of the program, at least 10,000 prisoners
are killed in Japanese experiments
1939 - Nomonhan Incident - Japanese poison Soviet
water supply with intestinal typhoid bacteria at former
Mongolian border. First use of biological weapons by Japanese
1940 - The Japanese drop rice and wheat mixed
with plague-carrying fleas over China and Manchuria
1942 - U.S. begins its offensive biological weapons
program and chooses Camp Detrick, Frederick, Maryland
as its research and development site May,
1945 - Only known tactical use of BW by Germany.
A large reservoir in Bohemia is poisoned with sewage (BW)28
September, 1950-February, 1951 - In a test of BW dispersal
methods, biological simulants are sprayed over San Francisco
June,
1966 - The United States conducts a test of vulnerability
to covert BW attack by releasing a harmless biological
simulant into the New York City subway system November
25,
1969 - President Nixon announces unilateral dismantlement
of the U.S. offensive BW program
February 14, 1970 - President Nixon extends the
dismantlement efforts to toxins, closing a loophole which
might have allowed for their production
1978 - In a case of Soviet state-sponsored assassination,
Bulgarian exile Georgi Markov, living in London, is stabbed
with an umbrella that injects him with a tiny pellet containing
ricin
April 2, 1979 - Outbreak of pulmonary anthrax
in Sverdlovsk, Soviet Union.
1992- Russian president Boris Yeltsin acknowledges
that the outbreak was caused by an accidental relase of
anthrax spores from a Soviet military microbiological
facility
1985-1991 - Iraq develops an offensive biological
weapons capability including anthrax, botulium toxin,
and aflatoxin.
3. Efforts
to Ban Biological Weapons
Using biological and chemical weapons was condemned by
international declarations and treaties, notably by the
1907 Hague Convention (IV) respecting the laws and customs
of war on land. Efforts to strengthen this prohibition
resulted in the conclusion, in 1925, of the Geneva Protocol
which banned the use of asphyxiating, poisonous or other
gases, usually referred to as chemical weapons, as well
as the use of bacteriological methods of warfare. The
latter are now understood to include not only bacteria,
but also other biological agents, such as viruses or rickettsiae
which were unknown at the time the Geneva Protocol was
signed. (On 1 January 1997, 132 States were party to this
Protocol.) However, the Geneva Protocol did not prohibit
the development, production and stockpiling of chemical
and biological weapons. Attempts to achieve a complete
ban were made in the 1930s in the framework of the League
of Nations, but with no success.
The prohibition of chemical and biological weapons appeared
on the agenda of the Eighteen-Nation Committee on Disarmament
in Geneva (now called the Conference on Disarmament)in
1968. One year later, the United Nations published an
influential report on the problems of chemical and biological
warfare, and the question received special attention at
the UN General Assembly. The UN report concluded that
certain chemical and biological weapons cannot be confined
in their effects in space and time and might have grave
and irreversible consequences for man (sic) and nature.
This would apply to both the attacking and the attacked
nations. Due to interest in the topic in the end of the
1960s, the Biological Weapons Convention was signed in
1972 and entered into force in 1975.
4.
What is the Biological and Toxin Weapons Convention?
The Biological Weapons Convention entered into force
in March 1975 after 22 governments had ratified, and was
the first multilateral disarmament treaty banning an entire
category of weapons of mass destruction. The Convention,
about four pages long, bans the development, production
stockpiling, or acquisition of biological agents or toxins
of any type or quantity that do not have protective, medical,
or other peaceful purposes, or any weapons or means of
delivery for such agents or toxins. Under the treaty,
all such materiel is to be destroyed within nine months
of the treaty's entry into force.
The Treaty has been ratified by 143 states and has review
conferences every five years, the next one will be in
November 2001.
5.
The Convention has a number of inadequacies
Unlike the Chemical Weapons Convention that has an unprecedented
on-site inspection provision, the Biological Weapons Convention
has no verification provisions.
The Convention has not defined the prohibited items nor
the targets to which the prohibitions relate. There exists,
however, an authoritative definition of biological warfare
agents formulated by the World Health organization (WHO).
In a 1970 report the WHO described biological warfare
agents as those that depend for their effects on multiplication
within the target organism and are intended for use in
war to cause disease or death in man (sic), animals or
plants; they may be transmissible or non-transmissible.
Toxins are poisonous products of organisms; unlike biological
agents, they are inanimate and not capable of reproducing
themselves. The Convention applies to all natural or artificially
created toxins, "whatever their origin or method of production"
(Article I). Thus, it covers toxins produced biologically,
as well as those produced by chemical synthesis. Since
toxins are chemicals by nature, their inclusion in the
BW Convention was a step towards the projected ban on
chemical weapons.
The term "other peaceful purposes" in the Convention
has remained unclear, a reason why the BW weapons control
has been so difficult. One can assume that it includes
scientific experimentation. Under the BW Convention, the
prohibition to develop, produce, stockpile or otherwise
acquire or retain biological agents and toxins is not
absolute. It applies only to types and to quantities that
have no justification for prophylactic, protective or
other peaceful purposes. The stipulation that any development,
production, stockpiling or retention of biological warfare
agents or toxins must be justified and does not carry
sufficient weight. Retention, production or acquisition
by other means of certain quantities of biological agents
and toxins to be used for hostile purposes may thus continue,
and there may be testing in laboratories and even in the
field which may lead to the development of more progressive
and sophisticated biological agents for the purpose of
warfare.
There are no provisions in the BW Convention restricting
biological research activities. This circumstance and
the express authorization to engage in production (for
peaceful purposes) of biological agents and toxins that
may be used in warfare create a risk that the provisions
of the Convention will be circumvented. There are no agreed
standards or criteria for the quantities of agents or
toxins that may be needed by different States for the
different purposes recognized by the Convention. The parties
are not even obliged to declare the types and amounts
of agents or toxins they possess and the use they make
of them.
6.
What is the Ad Hoc Group and what is it doing?
The Ad Hoc Group is working to strengthen the BWC with
a verification protocol.
The mandate to negotiate a Protocol on verification came
from the 1994 Special Conference of States Parties to
the BWC. The revelation that some states parties had been
discovered to have developed covert biological weapons
programmes added to the recognition that the effectiveness
and implementation of the BWC needed to be strengthened.
A group of governmental experts (VEREX) met from 1992-1993
to consider verification measures from a mostly technical
perspective . Negotiations on a Protocol began in earnest
in January 1995 in the current Ad Hoc Group (AHG) format.
The group meets several times a year for two to four weeks
each time and has now met for a total of about 60 weeks.
The group's work is to be completed by the Fifth Review
Conference. This Review Conference will take place in
November-December of 2001, preceded by a Preparatory Commission
in April.
By July 1997, the AHG had before it the first draft of
the verification protocol, the so called rolling text,
which it has since been negotiating on. The rate of progress
in removing brackets (which are the indicators of disagreement)
has varied over the last three years, and slowed down
recently. Only the most contentious issues in the Protocol
are left unresolved, and therefore discussion now centers
on the question of when a Chair's text (i.e. a text without
brackets, which shows the possible final shape of the
protocol) should be produced.
7. What
do Individual Governments have to do after they sign?
Under the future Protocol, States have to initially declare
past offensive and defensive BW programmes. They have
then to declare annually dual-use capabilities, such as
facilities with high biological containment, large production
facilities, facilities working with certain very dangerous
agents, and facilities working in the national biodefence
programmes. These declarations will randomly be checked
by on-site visits. If there are ambiguities in the declarations,
the future organization or individual states can request
a clarification, including a clarification visit. If a
state suspects that another state is violating the BTWC,
i.e. possesses or uses BW, it can request a short-notice
challenge investigation. Under the Protocol, States also
have to implement national legislation prohibiting their
citizens from engaging in activities prohibited by the
BTWC worldwide. Each State will have to set up a national
authority which is responsible for implementing the protocol
and cooperating with the future organization for the Prohibition
of Biological and Toxin Weapons.
8. Countries
Suspected of Possessing Biological Weapons
i) Russia
As revealed by Yeltsin, the Soviet Union maintained an
offensive biological weapons program from 1972 until 1992.
Yeltsin signed a decree in April 1992 to terminate its
offensive research, dismantled experimental biological
agent production lines, closed a biological weapons testing
facility, cut the number of personnel in the program by
fifty percent and the funding by thirty percent, and submitted
information about its biological weapons program to the
UN. According to its declaration, Russia maintained an
offensive research and development program until March
1992 that worked with anthrax, tularemia, brucellosis,
plague, Venezuelan equine encephalitis, typhus, and Q-fever.
With respect to toxins, Russia claimed that the only natural
toxin studied in its program was botulinum toxin. Apparently,
Russian scientists developed a genetically manipulated
strain of the plague.
ii)Iraq
Iraq had advanced facilities studying anthrax, botulism,
brucellosis, tularemia, and gas gangrene organisms were
found alongside a wide array of potential delivery systems
from aerial bombs to surface-to-air-missiles(SAM's). For
a complete timeline of Iraq's WMD program, see
iii) United States
On 14 February 1970, the United States also formally renounced
the production, stockpiling and use of toxins for war
purposes. It stated that military programmes for biological
agents and toxins would be confined to research and development
for defensive purposes
iv)UK
Great Britain abandoned its offensive biological weapons
capabilities in the late 1950s.
v)China
China, a member of the BWC since 1984, is believed to
have maintained an offensive biological weapons program
throughout most of the 1980s that included "development,
production, stockpiling or other acquisition or maintenance
of biological warfare agents
vi) Egypt
Egypt, a signatory but not a member of the BWC, has a
program of military-applied research in the area of biological
weapons dating back to the 1960s. No publicly available
data to date indicates that Egypt has produced its own
biological agents. Bilateral cooperation between US and
Egypt has resulted in a military-medical laboratory in
Egypt, recognized as one of the region's leading medical-biological
centers, equipped with the latest equipment and staffed
with highly qualified American specialists. The research
conducted by this laboratory is highly classified. The
US assessment is that it remains likely that Egypt continues
to maintain a capability to conduct biological warfare.
vii) Iran
Iran, which joined the CWC on 3 November 1997, has been
a member of the BWC since 1973. Iran conducts legitimate
biomedical research at various institutes, which are suspected
of involvement in this biological weapons program. The
Iranian military has used medical, education, and scientific
research organizations for many aspects of biological
agent procurement, research, and production. The US finding
is that Iran probably has produced biological agents and
apparently has weaponized a small quantity of those agents.
viii) Syria
Syria has signed but not ratified the BWC. Israel has
expressed concerns that Syria has biological agents for
contaminating drinking water. However, no reliable information
is available about the existence of biological weapons
in Syria or a directed program for the creation of an
offensive potential in the biological realm. Syria nonetheless
remains among those countries that the United States believes
to be developing an offensive biological warfare capability
ix)) Israel
Israel's national biological weapons program is unknown.
An Israeli biological weapons program is likely to be
patterned after those formerly maintained by the United
States and the former Soviet Union. In other words, the
agents likely to be involved in an Israeli program are
anthrax, botulinum toxin, tularemia, plague, Venezuelan
equine encephalitis, and Q-fever. Similarly, Israeli delivery
systems are likely to mirror those developed by the United
States, namely spray systems or missile warheads and submunitions.
Israel is one of the few states that has not signed the
BWC.
x) Libya
Libya is thought to be attempting to weaponize biological
agents, although little is known about Libya's biological
weapons program. While Libya has been a member of the
BWC since 1972, there is information indicating that it
is engaged in initial testing of biological weapons. Presently,
Libyans are expressing interest in information on work
overseas involving biological agents. Libya has also failed
to submit a confidence-building data declaration to the
UN. According to the US assessment, Libya is seeking to
acquire the capability to develop and produce biological
agents.
xi)North Korea
North Korea has been a member of the BWC since 1987. During
the early 1960s, North Korea initiated an offensive biological
warfare program. Presently, North Korea is engaged in
applied military-biological research at universities,
medical institutes, and specialized research centers.
Research at these centers involves pathogens for malignant
anthrax, cholera, and bubonic plague. Evidence indicates
that North Korea has been testing biological weapons on
its island territories.
xii)Taiwan
Taiwan, which joined the BWC in 1973, is another country
suspected of proliferating both chemical and biological
weapons. Taiwan is said not to have biological weapons,
but it continues to manifest an active interest in conducting
biological research of a military-applied nature. Taiwan
has a significant scientific and technical base in microbiology
and a large number of skilled biotechnology specialists,
mostly trained in America and Western Europe. Taiwan is
moving to upgrade its biotechnology sector, which makes
wide use of technologies basic to the production of biological
weapons.
9.
How can biological weapons be defended against?
Biological defense may be divided into the following
categories: prevention, protection, detection, treatment,
and decontamination.
Prevention
Prevention may take several forms. In the case of biological
warfare, international disarmament and inspection regimes
may deter production and dissemination of biological warfare
agents. Intelligence assets may indicate potential threats
and allow for preventative action to be undertaken.
Protection
Forms of protection against biological warfare agents
are limited in capacity. Protective suits, clothing, gas
masks and filters may provide limited protection for short
periods of time. However, the persistence of biological
agents such as anthrax makes such protections mainly useful
for military personnel and first responders. Anthrax can
remain active and potentially lethal for at least 40 years.
(source: Biological Warfare: A Historical Perspective)
It should be noted that anthrax is an exception, as most
other agents do not live that long. Protection (as detection
and treatment) of Biological Warfare is the establishment
and maintenance of a good health care system. In addition,
vaccination is a form of protection, which may provide
substantial protection against naturally occurring agents,
although vaccines often provide limited or no protection
against genetically engineered variants designed to defeat
such vaccines.
Detection
During the Gulf War, US and allied forces suffered from
a lack of reliable biological agent detection systems.
Subsequently, a number of detection systems have been
developed. Often it takes from a few hours to a few days
to detect exposure to a biological weapon. However, with
advances in biotechnology will help develop improved and
quicker detectors. Current detectors include: SMART (Sensitive
Membrane Antigen Rapid Test) JBPDS (Joint Biological Point
Detection System) BIDS (Biological Integrated Detection
System) IBAD (Interim Biological Agent Detector) (source:
Biological Warfare and Detection Capabilities) Treatment
Treatment options after infection depend on whether or
not the infectious agent is identified. If not identified,
massive doses of antibiotics may be given in hopes that
something may work. Again, treatment of victims of biological
warfare largely depends on the establishment and maintenance
of a good health care system. Decontamination Unlike chemical
weapons, which disperse over time, biological agents may
grow and multiply over time. Anthrax can remain active
in the soil for at least 40 years and is highly resistant
to eradication. (Source: Biological Warfare: A Historical
Perspective) However, the anthrax contaminated Gruinard
Island in the UK was decontaminated - decontamination
is possible, using chemicals, heat or rays (UV).
10.
What should WILPF groups do to support this treaty?
WILPF can serve an important role in raising awareness
about biological warfare. For example, there is the sign-on
initiative by The Sunshine Project (www.sunshine-project.org).
The principle challenge in addressing biological warfare
is to expose and prevent the misuse of biosciences. Therefore,
interaction with environmental and consumer protection
groups in relevant fields would be useful. Once the Protocol
exists, it will be very important to lobby for ratification,
although this will be an arduous fight, especially in
the United States.
11.
Other Conventions, Laws and Agreements Relating to Biological
Warfare and Biological Weapons
1. Protocol for the Prohibition of the Use in War
of Asphyxiating, Poisonous or Other Gases, and of Bacteriological
Methods of Warfare (The Geneva Protocol): Opened for
Signature: June 17, 1925, Entered into Force: February
8, 1928 The Geneva Protocol prohibits the use of all asphyxiationg,
poisonous, or other gases; all similar liquids, materials,
or devices; and all methods of bacteriological warfare
during war.
2. UK-US-Russian Joint Statement on Biological Weapons,
Meeting Held in Moscow, September 10-11, 1992 In a
joint statement issued at the conclusion of a trilateral
meeting, the governments of the United Kingdom, the United
States, and the Russian Federation affirmed their commitment
to full compliance with the 1972 BWC. In order to address
concerns about compliance, the states agreed on reciprocal
measures to remove any ambiguities. Measures include reciprocal
visits to military and non-military biological facilities,
and the convening of expert groups to ensure continued
compliance. U.S. and U.K. officials visited Russian sites
in October 1993 and January 1994. In February and March
1994, Russian officials visited three facilities in the
United States and one in Britain.
3. Environmental Modification Convention, entered
into force on October 5, 1978. In August 1975, the
chief representatives of the U.S. and the Soviet delegations
to the Conference of the Committee on Disarmament (CCD)
tabled, in parallel, identical draft texts of a "Convention
on the Prohibition of Military or any Other Hostile Use
of Environmental Modification Techniques." The Convention
defines environmental modification techniques as changing
-- through the deliberate manipulation of natural processes
-- the dynamics, composition or structure of the earth,
including its biota, lithosphere, hydro-sphere, and atmosphere,
or of outer space. The Convention entered into force on
October 5, 1978, when the 20th state to sign the Convention
deposited its instrument of ratification. The Convention
entered into force for the United States on January 17,
1980, when the U.S. instrument of ratification was deposited
in New York.
4. The Hague Convention (IV), Respecting the Laws
and Customs of War on Land, signed at The Hague, 18 October
1907. Section II: Hostilities. Chapter I: Means of
Injuring the Enemy, Sieges, and Bombardments Art. 22.
The right of belligerents to adopt means of injuring the
enemy is not unlimited. Art. 23. In addition to the prohibitions
provided by special Conventions, it is especially forbidden
- (a) To employ poison or poisoned weapons.
5. Chemical Weapons Convention on the Prohibition
of the Development, Production, Stockpiling and use of
Chemical Weapons and on their Destruction, was opened
for signature in 1993, and entered into force in 1997.
On January 13, 1993, in Paris, 130 countries signed the
Chemical Weapons Convention (CWC) to ban the entire class
of chemical weapons. Many of those nations have since
ratified it. In this country, debate continues on the
strategic implications of the convention, as drafted,
and whether it is in the U.S. national security interest.
This convention covers the toxins section in biological
weapons
12. Sources on biological weapons
Acronym Institute: Biological Weapons Convention
Arms Control Association: Biological Weapons: Documents,
News, and Analysis
Australia Group: Relationship with the Biological Weapons
Basic: A Guide to Biological Weapons Control (October
2001)
Carnegie Endowment for Internaitonal Peace. Proliferation
News and Resources
Center for Defence and International Security Studies:
Biological Weapons
Center for Defense Information's Chemical and Biological
Weapons Proliferation Web Site
Center for Nonproliferaton Studies, Monterey Institute
of International Studies: Chemical and Biological Weapons
Resource Page
*Including: Federal Agencies and Programs, Federal Publications,
Think Tanks and Non-Governmental Organizations, Journals
Federation of American Scientists: Chemical and Biological
Arms Control Program
Henry L. Stimson Center:. Chemical and Biological
Weapons Nonproliferat ion Project
John Hopkins University: Center for Civilian Biodefense
Studies
Pugwash Onlice: Chemical and Biological Weapons: Reports
and Statements
SIPRI: Stockholm International Peace Research Institute:
The Biological and Toxin Weapons Convention
SIPRI: Stockholm International Peace Research Institute:
Educational Module on Chemical and Biological Weapons
Nonproliferation
Sunshine Project: Research and facts about biological
weapons and biotechnology
United Nations Institute for Disarmament Research (UNIDIR):
Biological Weapons: from the BWC to Biotech
University of Bradford, Peace Studies Department: Preventing
Biological Warfare: Strengthening the Biological and Toxin
Weapons Convention
Verification Research, Training and Information Centre
(VERTIC), Promoting effective verification of the 1972
Biological Weapons Convention
13.
Meetings of States Parties to the Biological and Toxin
Weapons Convention
Chair: Ambassador Georgi Avramchev (The Former Yugoslav
Republic of Macedonia)
by Richard Guthrie for the Bioweapons Prevention
Project and the Acronym Institute for Disarmament Diplomacy
The Meeting of States Parties was chaired by Ambassador
Masood Khan of Pakistan. In accordance with the decision
of the Sixth Review Conference, the Meeting of States
Parties considered the work of the Meeting of Experts
(20-24 August 2007) to discuss, and promote common understanding
and effective action on:
1. Ways and means to enhance national implementation,
including enforcement of national legislation, strengthening
of national institutions and coordination among national
law enforcement institutions.
2. Regional and sub-regional cooperation on implementation
of the Convention.
The 2007 Meeting of Experts (MX) held in Geneva from 20-24
August was chaired by Ambassador Masood Khan of Pakistan.
The meeting discussed national implementation, enforcement
of national legislation, strengthening national institutions,
coordination amongst law enforcement, and regional and sub-regional
cooperation on implementation. Read daily reports from the
MX from the BioWeapons Prevention Project .
Read the final document of the MX .
The , created by a decision of the Sixth
Review Conference in December, 2006, was at the Palais. The ISU Will provide
institutional support for the implementation of the BWC, facilitate
communication between States Parties, scientific and academic
institutions, and NGOs, and work to promote the universalization
of the BWC.
The Sixth Review Conference of the States Parties to the
Biological Weapons Convention was held in Geneva from 20 November
to 8 December 2006 in Geneva. Ambassador Masood Khan (Pakistan)
presided over the Review Conference.
In accordance with the decision taken at the Fifth Review
Conference of the States parties to the Biological Weapons
Convention (BWC), the 2004 Meeting of the States Parties was
held from 5 to 9 December 2005 in order to discuss and promote
understanding and effective action on the content, promulgation,
and adoption of codes of conduct for scientists.
Ambassador John Freeman of the United Kingdom served as Chairman
of the 2005 meetings.
The Biological and Toxin Weapons Convention Meeting of Experts
took place July 19-30 in Geneva.
Among the other items on their agenda, the experts discussed
disease surveillance, strengthening and broadening national
and international efforts in accordance with the BTWC, mitigating
the effects of cases of alleged use of biological or toxin
weapons, and more.
Provisional agenda The Programme of work
The background paper
prepared by the Secretariat on "Consideration of enhancing
international capabilities for responding to, investigating
and mitigating the effects of cases of alleged use of biological
or toxin weapons or suspicious outbreaks of disease."
Conference of the States Parties,
November 10-14, 2003.
The States Party to the BTWC met in Geneva,
November 10-14, 2003.
BWC/MSP.2003/WP.1
- Working Paper Submitted by the Netherlands BWC/MSP.2003/WP.2 - Working
Paper Submitted by the Federal Republic of Germany: Core Elements
of National Measures to Implement the Prohibitions Contained
in the BTWC BWC/MSP.2003/WP.3 - Working
Paper Submitted by the Federal Republic of Germany: Core Elements
of National Measures to Establish and Maintain the Security
and Oversight of Dangerous Microoragnisms and Toxins BWC/MSP.2003/WP.4 - Working
Paper Submitted by the Federal Republic of Germany: Sources
of Expert Advice on National BTWC Implementing Legislation
and Legislation on Security and Oversight of Dangerous Pathogens
in the Federal Republic of Germany BWC/MSP.2003/WP.5 - Working
Paper Submitted by Japan: Japan's BWC Implementing Law BWC/MSP.2003/WP.6 - Working
Paper Submitted by the Russian Federation: Answers to the
Questionnaire on National Legislation Ensuring Compliance
with the Convention on the Prohibition of Biological and Toxin
Weapons BWC/MSP.2003/WP.7 - Working
Paper Submitted by the Russian Federation: On the Procedure
for the Management of Microorganisms of the Pathogenicity
Groups I-IV in the Territory of the Russian Federation BWC/MSP.2003/WP.8 - Working
Paper Submitted by Italy: The Italian National Committee for
Bio-safety and Biotechnology BWC/MSP.2003/WP.9 - Working
Paper Submitted by Switzerland: National Survellance of Activities
with Pathogenic and Genetically Modified Organisms: Offer
to Share Expertise with Interested States Parties of the BWC BWC/MSP.2003/WP.10 - Working
Paper Submitted by the Netherlands